Bristol-Myers Squibb
BMY
$48.30
Share price
0.96%
Change (1 day)
-31.23%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total assets
Total assets on the balance sheet as of December 2023 : $95.15 B
According to Bristol-Myers Squibb's latest financial reports the company's total assets are $95.15 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bristol-Myers Squibb - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $95.15 B | -1.72% |
| 2022-12-31 | $96.82 B | -11.43% |
| 2021-12-31 | $109.31 B | -7.74% |
| 2020-12-31 | $118.48 B | -8.82% |
| 2019-12-31 | $129.94 B | 271.42% |
| 2018-12-31 | $34.98 B | 4.28% |
| 2017-12-31 | $33.55 B | -0.46% |
| 2016-12-31 | $33.70 B | 6.17% |
| 2015-12-31 | $31.74 B | -5.93% |
| 2014-12-31 | $33.74 B | -12.55% |
| 2013-12-31 | $38.59 B | 7.51% |
| 2012-12-31 | $35.89 B | 8.88% |
| 2011-12-31 | $32.97 B | 6.09% |
| 2010-12-31 | $31.07 B | 0.22% |
| 2009-12-31 | $31.00 B | 5.16% |
| 2008-12-31 | $29.48 B | 12.66% |
| 2007-12-31 | $26.17 B | 2.33% |
| 2006-12-31 | $25.57 B | -9.11% |
| 2005-12-31 | $28.13 B | -7.55% |
| 2004-12-31 | $30.43 B | 10.88% |
| 2003-12-31 | $27.44 B | 9.7% |
| 2002-12-31 | $25.02 B | -10.03% |
| 2001-12-31 | $27.81 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 76.08% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | 5.03% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 138.02% | 🇺🇸 USA |
 AbbVie ABBV | $134.71 B | 41.56% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | -32.74% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 2.10% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 46.93% | 🇫🇷 France |
 Biogen BIIB | $26.84 B | -71.79% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 12.10% | 🇺🇸 USA |
 AstraZeneca AZN | $101.11 B | 6.26% | 🇬🇧 UK |